The global neurovascular devices market size in 2026 is witnessing strong growth as healthcare systems increasingly focus on the diagnosis and treatment of neurovascular conditions. Neurovascular devices include stenting systems, embolization devices, neurothrombectomy devices, and support devices used in the treatment of conditions such as cerebral aneurysms and ischemic stroke. According to Fortune Business Insights, the global neurovascular devices market size was valued at USD 4.08 billion in 2025 and is projected to grow from USD 4.46 billion in 2026 to USD 9.82 billion by 2034, exhibiting a CAGR of 10.40% during the forecast period. North America dominated the global market with a 43.60% share in 2025.

Neurovascular devices are specialized medical products designed for minimally invasive procedures involving blood vessels in the brain and surrounding areas. These devices support the management of neurovascular disorders, including cerebral aneurysms and ischemic stroke. Stenting systems, embolization devices, and neurothrombectomy devices represent important product categories within the market. The increasing prevalence of neurovascular conditions, particularly among the geriatric population, is contributing to demand for these products. Growing healthcare expenditure, improved awareness of treatment options, reimbursement policies, and advances in medical technology are also supporting the adoption of neurovascular interventions.

Top Companies In The Market

• Medtronic

• Penumbra, Inc.

• Stryker

• Johnson and Johnson Services, Inc. (CERENOVUS)

• MicroPort Scientific Corporation

• Acandis GmbH

• MicroVention, Inc.

• NeuroVasc Technologies, Inc.

• ASAHI INTECC CO., LTD.

• Perflow Medical Ltd.

Market Drivers & Restraints

The rising incidence of neurovascular conditions is a major factor supporting market growth. The Fortune Business Insights report highlights the increasing prevalence of stroke, cerebral aneurysms, and other neurological conditions globally. The burden of these diseases is particularly significant among the aging population. Increasing healthcare expenditure and awareness of effective treatment options are encouraging more patients to undergo neurovascular procedures.

Government initiatives and healthcare organizations are also focusing on improving awareness, diagnosis, and management of neurological disorders. Such initiatives, combined with improving healthcare infrastructure in emerging countries, are expected to support the adoption of neurovascular devices.

Technological advancement is another important market driver. Market participants are investing in research and development to introduce advanced embolic coils, aspiration catheters, revascularization devices, and other products. Clinical studies are also being conducted to establish the efficiency of pipeline technologies and address unmet needs in neurovascular intervention.

However, limitations associated with diagnosis and treatment may restrict market expansion. Delayed diagnosis and misdiagnosis of brain aneurysms remain challenges, particularly where brain imaging facilities, specialized expertise, healthcare infrastructure, and established treatment guidelines are limited. These factors can affect timely treatment and consequently limit the adoption of neurovascular devices in certain markets.

Market Competitive Landscape

The competitive landscape includes established medical device companies and emerging participants focusing on technological development and product expansion. Stryker, Medtronic, Terumo Corporation, and Penumbra, Inc. accounted for a major portion of the market share in 2024, according to Fortune Business Insights.

Companies are emphasizing research and development, advanced product portfolios, clinical studies, collaborations, and geographic expansion. Stryker has invested in neurovascular research and development infrastructure, while Medtronic has focused on product launches and technologies for neurological conditions. Other companies are also investing in advanced technologies designed to address the increasing demand for neurovascular treatment solutions.

Market Segments

By Device Type (Stenting Systems, Embolization Devices, Neurothrombectomy Devices, and Support Devices)

By Application (Cerebral Aneurysms, Ischemic Stroke, and Others)

By End-user (Hospitals, Specialty Clinics, and Others)

Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/industry-reports/neurovascular-devices-interventional-neurology-market-101684 

Market Regional Insights

North America dominated the global neurovascular devices market with a 43.60% share in 2025, generating USD 1.78 billion in revenue. The regional market is projected to reach USD 1.96 billion in 2026. Growing prevalence of neurological disorders, higher diagnosis and treatment rates, healthcare expenditure, and reimbursement policies are supporting market growth. The U.S. market is projected to reach USD 1.88 billion in 2026.

Europe reached USD 1.06 billion in 2025, accounting for a 26.00% share of the global market, and is expected to reach USD 1.16 billion in 2026. Product launches, new approvals, and efforts by prominent market participants to expand their geographical presence are contributing to regional development.

Asia Pacific generated USD 0.96 billion in 2025, representing 23.60% of global market revenue, and is projected to reach USD 1.05 billion in 2026. Strategic initiatives, increasing awareness, and improving healthcare infrastructure are supporting the regional market.

Latin America generated USD 0.17 billion in 2025 and represented 4.30% of the global market. The region is expected to reach USD 0.19 billion in 2026. 

Future Market Scope

The future scope of the neurovascular devices market is closely associated with increasing demand for minimally invasive neurological procedures, technological development, and the growing burden of neurovascular diseases. Market participants are focusing on advanced embolization devices, aspiration catheters, stent-retrievers, and other solutions to address unmet treatment needs. Growing investments in research and development, clinical studies, product launches, collaborations, and geographic expansion are expected to create additional opportunities. Improvements in healthcare infrastructure and increasing awareness of neurovascular diseases may further support adoption across emerging markets.

What’s Driving Japan’s Market? Discover the Latest -Neurovascular Devices/Interventional Neurology Market- Insights